HIV-associated cryptococcal disease. Indicators of poor prognosis;Criptococosis diseminada en pacientes con sida. Factores pronosticos de mala evolucion

Medicina Clinica

Volumn 112, Issue 11, 1999, Pages 401-405

  Alonso, Mar ^a   García, Felipe ^b   Mallolas, Josep ^c   Soriano, Alex ^c   Ortega, Mar ^c   Miró, José María ^c   Gatell, José María ^c   Soriano, Eladio ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FUNGUS ANTIGEN; TRIAZOLE;

ADULT; AGED; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOSIS; PROGNOSIS; RELAPSE; THRUSH; TREATMENT OUTCOME;

EID: 0033608792     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Diamond R, Bennett J. Prognostic factors in cryptococcal meningitis. Ann Intern Med 1974; 80: 176-181.
2. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon C. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533-538.
3. Miró JM, Mallolas J, Moreno A, Marco F, García F. Infecciones por Cryptococcus neoformans en pacientes infectados y no infectados por el VIH. Rev Clin Esp 1997; 197 (Supl 1): 44-48.
4. Sugar AM, Stern JJ. Overview: treatment of cryptococcal meningitis. Rev Infect Dis 1990; 12 (Supl): 338-348.
5. Pradier C, Bernard E, Lubick C, Toussaint-Gari M, Pinier Y, Durant J et al. Does fluconazole prevent cryptococcal meningitis in human immunodeficiency virus-infected patients? J Infect Dis 1992; 165: 787.
6. Pedrol E, Mallolas J, González-Clemente JM, Miró JM, Azón A, Gatell JM et al. Criptococosis: presentación de 26 casos. Med Clin (Barc) 1992; 98: 361-365.
7. Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337: 15-21.
8. Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM et al. A randomized controlled trial of fluconazole versus amphotericin B as maintenance therapy for prevention of relapse of criptococcal meningitis in patients with AIDS. N Engl J Med 1992; 326: 793-798.
9. Eng R, Bishburg E, Smith S. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986; 81: 19-23.
10. Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of criptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994; 18: 789-792.
11. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83-89.
12. Chuck Steven L, Sande Merle A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 794-799.
13. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 1987; 317: 334-341.
14. Clark RA, Greer D, Atkinson W, Valainis DT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990; 12: 768-777.
15. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahel JJ. Cryptococcal disease in patients with acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986; 104: 234-240.
16. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17: 837-842.
17. Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kerndt PR. Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County. AIDS 1997; 11: 673-679.
18. Newton JA, Tasker SA, Bone WD, Oldfield EC, Olson PE, Nguyen MT et al. Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection. AIDS 1995; 9: 1.286-1.287.
19. Butler WT, Alling DW, Spickard A, Utz JP. Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis: a follow-up study of forty patients. N Engl J Med 1964; 270: 59-67.
20. Moosa MYS, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. Clin Infect Dis 1997; 24: 131-134.
21. Martínez E, Domingo P, Ris J. Cerebrospinal fluid adenosine deaminase levels in a patient with cryptococcal meningitis. Clin Infect Dis 1992; 15: 1.061-1.062.